Hedi Mammeri - Concepedia

Author

Hedi Mammeri

Assistance Publique – Hôpitaux de Paris ORCID

Also Known As

H. Mammeri, Hedi Mammeri, Marlène Amara

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Assistance Publique – Hôpitaux de Paris Bicêtre Hospital Centre Hospitalier Universitaire Amiens-Picardie Inserm Hôpital Nord

About

Hedi Mammeri is an author at Assistance Publique – Hôpitaux de Paris specializing in microbiology, clinical microbiology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.1K
2	Health Sciences	12	12	1K
3	Biochemistry	5	5	189
4	Natural Sciences	2	2	114
5	Engineering	1	1	22

Hedi Mammeri

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Origin of Plasmid-Mediated Quinolone Resistance Determinant QnrA Laurent Poirel, José Manuel Rodríguez-Martínez, Hedi Mammeri, Antimicrobial Agents and Chemotherapy Antibiotic Resistance GenePharmacotherapyAntimicrobial ChemotherapyAntibiotic ResistanceDrug Resistance	2005	375
Emergence of Plasmid-Mediated Quinolone Resistance in <i>Escherichia coli</i> in Europe Hedi Mammeri, Marc Van De Loo, Laurent Poirel, Antimicrobial Agents and Chemotherapy Plasmid-mediated Quinolone ResistanceGeneticsMolecular BiologyAntibiotic ResistanceAntibiotic Resistance Genes	2004	257
Chromosome-Encoded β-Lactamases TUS-1 and MUS-1 from <i>Myroides odoratus</i> and <i>Myroides odoratimimus</i> (Formerly <i>Flavobacterium odoratum</i> ), New Members of the Lineage of Molecular Subclass B1 Metalloenzymes Hedi Mammeri, Samuel Bellais, Patrice Nordmann Antimicrobial Agents and Chemotherapy GeneticsBacteriologyMolecular BiologyEscherichia ColiMolecular Genetics	2002	93
Phenotypic and Biochemical Comparison of the Carbapenem-Hydrolyzing Activities of Five Plasmid-Borne AmpC β-Lactamases Hedi Mammeri, Hélène Guillon, François Eb, Antimicrobial Agents and Chemotherapy Carbapenem-hydrolyzing ActivitiesAntimicrobial Resistance GeneHealth SciencesBiochemistryNatural Sciences	2010	92
Contribution of extended-spectrum AmpC (ESAC) β-lactamases to carbapenem resistance in Escherichia coli Hedi Mammeri, Patrice Nordmann, Amira Berkani, FEMS Microbiology Letters	2008	79
Association of Plasmid-Mediated Quinolone Resistance with Extended-Spectrum β-Lactamase VEB-1 Laurent Poirel, Marc Van De Loo, Hedi Mammeri, Antimicrobial Agents and Chemotherapy	2005	79
Resistance to Cefepime and Cefpirome Due to a 4-Amino-Acid Deletion in the Chromosome-Encoded AmpC β-Lactamase of a <i>Serratia marcescens</i> Clinical Isolate Hedi Mammeri, Laurent Poirel, Pascal Bemer, Antimicrobial Agents and Chemotherapy	2004	70
Chromosomal Integration of a Cephalosporinase Gene from <i>Acinetobacter baumannii</i> into <i>Oligella urethralis</i> as a Source of Acquired Resistance to β-Lactams Hedi Mammeri, Laurent Poirel, N. Mangeney, Antimicrobial Agents and Chemotherapy	2003	70
Naturally Occurring Extended-Spectrum Cephalosporinases in <i>Escherichia coli</i> Hedi Mammeri, Laurent Poirel, Nicolas Fortineau, Antimicrobial Agents and Chemotherapy	2006	63
Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations Hervé Dupont, Olivier Gaillot, Anne-Sophie Goetgheluck, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeBacterial PathogensDrug ResistanceMedical MicrobiologyNovel Ceftazidime-avibactam	2015	63

Page 1